The therapeutic effectiveness of 177Lu-lilotomab in B-cell non-Hodgkin lymphoma involves modulation of G2/M cell cycle arrestAlexandre Pichard, Jean‐Pierre Pouget, Jihad Karam et al.|Leukemia|2019Cited by 25